They reported that an increased level of urinary MCP1 was strongly associated with a decline in the renal function in patients with diabetes, suggesting that excreted MCP1 levels may be a useful biomarker for predicting progressive decline in DKD [20]. Here, CCL2 is linked to diabetic kidney disease.